The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomasz Wójcik, Bożena Karolko, Jerzy Wiśniewski, Andrzej Mysiak, Krzysztof Ściborski, Grzegorz Onisk, Arleta Lebioda, Anna Jonkisz, Marcin Protasiewicz
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	active clopidogrel metabolite acute coronary syndrome abcb1 cyp2c19. Medicine R
Acceso en línea:	https://doaj.org/article/0f0ab7c1a8be46fcb560011e301d8a48
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0f0ab7c1a8be46fcb560011e301d8a48
record_format	dspace
spelling	oai:doaj.org-article:0f0ab7c1a8be46fcb560011e301d8a482021-12-02T19:19:13ZThe influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms1734-93381897-429510.5114/aic.2021.106894https://doaj.org/article/0f0ab7c1a8be46fcb560011e301d8a482021-07-01T00:00:00Zhttps://www.termedia.pl/The-influence-of-acute-coronary-syndrome-on-the-levels-of-clopidogrel-active-metabolite-and-platelet-inhibition-in-patients-with-and-without-CYP2C19-and-ABCB1-gene-polymorphisms,35,44380,1,1.htmlhttps://doaj.org/toc/1734-9338https://doaj.org/toc/1897-4295Tomasz WójcikBożena KarolkoJerzy WiśniewskiAndrzej MysiakKrzysztof ŚciborskiGrzegorz OniskArleta LebiodaAnna JonkiszMarcin ProtasiewiczTermedia Publishing Housearticleactive clopidogrel metabolite acute coronary syndrome abcb1 cyp2c19.MedicineRENAdvances in Interventional Cardiology, Vol 17, Iss 2, Pp 179-186 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	active clopidogrel metabolite acute coronary syndrome abcb1 cyp2c19. Medicine R
spellingShingle	active clopidogrel metabolite acute coronary syndrome abcb1 cyp2c19. Medicine R Tomasz Wójcik Bożena Karolko Jerzy Wiśniewski Andrzej Mysiak Krzysztof Ściborski Grzegorz Onisk Arleta Lebioda Anna Jonkisz Marcin Protasiewicz The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms
format	article
author	Tomasz Wójcik Bożena Karolko Jerzy Wiśniewski Andrzej Mysiak Krzysztof Ściborski Grzegorz Onisk Arleta Lebioda Anna Jonkisz Marcin Protasiewicz
author_facet	Tomasz Wójcik Bożena Karolko Jerzy Wiśniewski Andrzej Mysiak Krzysztof Ściborski Grzegorz Onisk Arleta Lebioda Anna Jonkisz Marcin Protasiewicz
author_sort	Tomasz Wójcik
title	The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms
title_short	The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms
title_full	The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms
title_fullStr	The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms
title_full_unstemmed	The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms
title_sort	influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without cyp2c19 and abcb1 gene polymorphisms
publisher	Termedia Publishing House
publishDate	2021
url	https://doaj.org/article/0f0ab7c1a8be46fcb560011e301d8a48
work_keys_str_mv	AT tomaszwojcik theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT bozenakarolko theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT jerzywisniewski theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT andrzejmysiak theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT krzysztofsciborski theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT grzegorzonisk theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT arletalebioda theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT annajonkisz theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT marcinprotasiewicz theinfluenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT tomaszwojcik influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT bozenakarolko influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT jerzywisniewski influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT andrzejmysiak influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT krzysztofsciborski influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT grzegorzonisk influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT arletalebioda influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT annajonkisz influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms AT marcinprotasiewicz influenceofacutecoronarysyndromeonthelevelsofclopidogrelactivemetaboliteandplateletinhibitioninpatientswithandwithoutcyp2c19andabcb1genepolymorphisms
_version_	1718376837528158208

The influence of acute coronary syndrome on the levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19 and ABCB1 gene polymorphisms

Ejemplares similares